I commend the Government, because I know that the motivations behind the measures they are trying to adopt are worthy. They believe that these measures represent the best way forward and I respect that point of view. They have done a great job on PPE, the acceleration of vaccine development and the rolling out of mass testing, as my right hon. Friend the Member for Tunbridge Wells (Greg Clark) just observed.
I thank the Prime Minister, his office and the Government for interacting with Back Benchers in an open and co-operative way. It is our duty as Members of Parliament to make informed decisions on behalf of our constituents and our country—to be able to say that we have chosen the best measures to save lives and jobs and to make sure that we have tax revenue for the future. It seems to me that this is not a zero-sum game: there is not just one option—the Government’s option—or no option at all. That is certainly not the case; there are all sorts of alternatives.
We could take a targeted approach, as in Germany; a borough-based approach, as my right hon. Friend the Member for Tunbridge Wells just mentioned; or even a targeted approach based on the individual premises where there may be an outbreak. We could decide to use a strategy in which we trust people more, offering more guidance and allowing people to make up their own minds about what they are going to do. We need to look at the evidence around that kind of approach.
We could continue to conduct intensive research into whether or not hospitality does spread the virus, along with all sorts of other areas. We could look at triage at hospitals to see whether the bar should be lowered slightly or raised slightly depending on the demand for hospital beds. We could also accelerate and refine test and trace. There are plenty of alternatives.
It seems to me that we have to focus on the harms versus the benefits. Whenever any one of us makes a decision in our own daily lives—about an investment or buying a house, for example—we think about the long-lasting consequences: the costs and the benefits. When it comes to personal healthcare, we go to see a consultant, who makes it clear that there are alternative treatments and sets out the relative benefits and harms of those various treatments. When it comes to business, if one is going to make an investment, one will always do a cost-benefit analysis in the long-term. In this place, we virtually always see an economic analysis, an impact assessment or an analysis based on quality-of-life indicators.
When it comes to this decision, however, we do not have a cost-benefit analysis, we do not have an economic impact assessment, and we do not have a health and harms analysis based on QOLIs, so it is with deep regret that I find it incredibly hard to back the Government today. However, I hope that in the future we will see proper health and economic impact assessments for proposed actions, as we will have a lot more actions to
consider around vaccines and testing. It is our duty to make an informed choice, but I do not feel that we are in a position to make that choice. The Government will probably have their way today, but I hope that in a few weeks’ time we will assess this more carefully and perhaps make a different judgment.
3.50 pm